Comparison of mRNA-1273 and BNT162b2 Vaccines on Breakthrough SARS-CoV-2 Infections, Hospitalizations, and Death During the Delta-Predominant Period

Key Points

Key points are not available for this paper at this time.

Abstract

This study examines breakthrough SARS-CoV-2 infections, hospitalizations, and mortality in March-August 2021, when the Delta variant predominated, among a general US cohort vaccinated with mRNA-1273 or BNT162b2.

Bookmark

View Full Paper

Cite This Study

Wang et al. (Thu,) studied this question.

synapsesocial.com/papers/6a1bd53c67ec8852715eda1d https://doi.org/https://doi.org/10.1001/jama.2022.0210

Bookmark

View Full Paper